Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Clinical research Stories

2014-04-08 08:30:15

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/92wf5v/animal) has announced the addition of a new report "Animal Biotechnology - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/92wf5v/animal ] to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes and evaluates animal biotechnology and its application in...

2014-04-07 23:29:20

On February 18, the FDA issued an eagerly awaited, clarifying final guidance, Requests for Feedback on Medical Device Submissions, which helps speed the FDA approval process by giving an early take on how the agency is viewing the submission work. This must-attend event will give a fuller understanding of the new guidance and show how to turn it into a beneficial and powerful approval tool. Falls Church, VA (PRWEB) April 07, 2014 The FDA’s New Device Pre-Submission Program: What Does...

2014-04-07 23:29:00

As the FDA announced on March 31, specific Nova Products Inc. dietary supplements for sexual enhancement are recalled because they were found to contain undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 07, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts...

2014-04-07 23:25:41

MarketReportsOnline.com adds "Chinese guidebook for Adverse Drug Reaction Reporting and Monitoring Regulations (2014)" report to its research store. Dallas, Texas (PRWEB) April 07, 2014 China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with a sustained economic and population growth, Chinese healthcare market has maintained an annual average growth rate above 16% since...

2014-04-07 12:34:11

LONDON, April 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013 Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013 SummaryGlobalData's clinical trial report, "Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013" provides data on the Ventricular Arrhythmia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2014-04-07 08:29:21

TORONTO, April 7, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI) (TSX: TTH) provided an update on the development of its drug candidates and plans for future growth. The addition of the neuropsychiatric drug candidate ELND005 has broadened the Company's development pipeline with an un-partnered late-stage clinical asset, coupled with Transition's core strategy of advancing assets acquired from pharmaceutical partners. From a...

2014-04-07 08:29:04

BOSTON, April 7, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced Dr. Roland Andersson, Ph.D., and Dr. Thomas Senderovitz, M.D., as Senior Vice Presidents in the Company's Clinical Research Services (CRS) strategic business unit. The executives will be centrally involved in developing and implementing PAREXEL's global corporate objectives. "Roland Andersson and Thomas Senderovitz further strengthen...

2014-04-07 04:21:16

MADISON, Wis., April 7, 2014 /PRNewswire/ -- The European Medicines Agency (EMA) has granted Minor Use Minor Species (MUMS) designation for Nexcyon's adrenocorticotropin (ACTH), a synthetic peptide for the diagnosis of hypoadrenocorticism in dogs. Hypoadrenocorticism, also known as Addison's Disease, can be difficult to diagnose without the aid of an ACTH injection. Nexcyon has developed a proprietary form of synthetic ACTH specifically formulated for use in dogs. Presently, when...

2014-04-05 23:00:15

MarketReportsOnline.com adds “Singapore Clinical Trial Market Analysis” report to its research store. Dallas, Texas (PRWEB) April 06, 2014 Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in the entire region. Singapore is the third largest market in Asia for conducting clinical trials. The...

2014-04-04 23:34:34

Innovative Adaptive Designs Increase Trial Flexibility and Efficiency, Generating Significant Ethical and Economic Advantages Reston, Virginia (PRWEB) April 03, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of product development, will present emerging strategies for using adaptive trial designs to improve the success...